Cambridge Investment Research Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,581 shares of VRTX stock, worth $6.45 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,581
Previous 14,517
13.34%
Holding current value
$6.45 Million
Previous $6.75 Million
24.96%
% of portfolio
0.02%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.5 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.14 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.35 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $132B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...